ACLX vs CUBE · rev $107.9M vs P/E 25, rev $1.07B
Arcellx Inc (ACLX) versus CubeSmart (CUBE) — a side-by-side from cached financials, not a winner call.
Arcellx Inc (ACLX) is a biotechnology company listed on NASDAQ.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Latest reported ACLX revenue for 2024-12-31 was $107.9M. Net income was -$107.3M. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. ACLX currently screens at market cap $6.73B.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
ACLX currently screens at market cap $6.73B. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Not investment advice. Open the ACLX and CUBE stock pages for the full models.
Not investment advice.